Indaptus Therapeutics (INDP) closed at $3.33 on October 28, 2026, up 0.8% from the previous close, on volume of 210,949 shares (30-day average 546,612).
Data as of October 28, 2026.
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
Seeking Alpha News (Thu, 29-Oct 3:12 PM ET)
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Globe Newswire (Thu, 13-Aug 7:00 AM ET)
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.
Indaptus Therapeutics trades on the NASDAQ stock market under the symbol INDP.
As of October 29, 2026, INDP stock price climbed to $3.35 with 54,834 million shares trading.
INDP has a beta of 0.69, meaning it tends to be less sensitive to market movements. INDP has a correlation of 0.00 to the broad based SPY ETF.
INDP has a market cap of $446.36 million. This is considered a Small Cap stock.
In the last 3 years, INDP traded as high as $91.00 and as low as $.92.
The top ETF exchange traded funds that INDP belongs to (by Net Assets): VXF, MSSM.
INDP has underperformed the market in the last year with a return of -2.9%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INDP shares. However, INDP has outperformed the market in the last 3 month and 2 week periods, returning +93.6% and +51.6%, while SPY returned +4.0% and -0.2%, respectively. This indicates INDP has been having a stronger performance recently.
INDP support price is $3.03 and resistance is $3.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INDP shares will trade within this expected range on the day.
